Jim Simons’s Orphazyme A/S ORPH Stock Holding History

Jim Simons’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-271,994	Closed	-$656K	–	4629
2021 Q4	$656K	Buy	271,994 +163,194	+150%	+$576K	﹤0.01%	2949
2021 Q3	$447K	Buy	108,800 +82,000	+306%	+$422K	﹤0.01%	2928
2021 Q2	$197K	Buy	+26,800	New	+$216K	﹤0.01%	3251

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Jim Simons's ORPH Position: Q1 2022 in Review

Jim Simons sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 271,994 shares — an estimated $656K sold.

Jim Simons first reported a position in ORPH in Q2 2021 and held it in 3 quarters. The position peaked at $656K in Q4 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Jim Simons reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Jim Simons sold 271,994 Orphazyme A/S shares in Q1 2022, an estimated $656K.
Jim Simons first reported a position in Orphazyme A/S in Q2 2021 and held it in 3 quarters.
Jim Simons's Orphazyme A/S position peaked at $656K in Q4 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.